Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-018530

President and CEO acquired 59,701 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schultz Kare · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-04 Exercise or conversion : show line 1 in the form +59,701 860,582 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-04 Exercise or conversion : show line 2 in the form Restricted Share Units −59,701 119,403 D
2021-03-05 Grant or award : show line 3 in the form Restricted Share Units +285,171 285,171 D
Loading xslF345X03/doc4.xml…